Synapses-associated research in Parkinson’s disease: an explored trends analysis

Synapses-associated research in Parkinson’s disease: an explored trends analysis

BackgroundThe pathological features of Parkinson’s disease (PD) include the formation of Lewy bodies composed mainly of aggregated alpha-synuclein (α-Syn) and extensive neurodegeneration. Synaptic dysfunction is a key factor contributing to disease progression among the various cellular and molecula...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yan-Jun Chen, Ming-Rong Xie, Sheng-Qiang Zhou, Fang Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson’s disease synapses synaptic plasticity neuroinflammation alpha-synuclein
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2025.1537119/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glutamate-associated research in Parkinson’s disease: a bibliometric analysis
by: Yan-Jun Chen, et al.
Published: (2025-08-01)

Astrocytes-associated research in Parkinson’s disease: an explored trends analysis
by: Yan-Jun Chen, et al.
Published: (2025-03-01)

Early α-synuclein aggregation decreases corticostriatal glutamate drive and synapse density
by: Charlotte F. Brzozowski, et al.
Published: (2025-06-01)

A Low-Cost Flexible Optoelectronic Synapse Based on ZnO Nanowires for Neuromorphic Computing
by: Yongqing Yue, et al.
Published: (2024-12-01)

The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
by: Haoran Xiang, et al.
Published: (2025-04-01)

Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
by: Lucia Lage, et al.
Published: (2025-03-01)

Interactions of alpha-synuclein with membranes in Parkinson's disease: Mechanisms and therapeutic strategies
by: Baoyi Li, et al.
Published: (2024-10-01)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
by: Oh‐Chan Kwon, et al.
Published: (2021-03-01)

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
by: Chuchu Wang, et al.
Published: (2024-12-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Targeting the gut to protect from ascending pathology in the paraquat and lectin model of Parkinson's disease
by: Caroline Swain, et al.
Published: (2024-11-01)

Does Parkinson's disease start in the gut?
by: Oscar S. Gershanik

Activity-dependent synapse elimination requires caspase-3 activation
by: Zhou Yu, et al.
Published: (2025-06-01)

Tailoring Dynamic Synaptic Plasticity in FeTFT Optoelectronic Synapse for Associative Learning
by: Peng Yang, et al.
Published: (2025-05-01)

Synthesis and preliminary biological evaluation of a novel PET tracer for α-synuclein PET imaging
by: WANG Ce, et al.
Published: (2024-10-01)

Editorial: Molecular mechanisms of glutamatergic synapse function and dysfunction, volume II
by: Dhrubajyoti Chowdhury, et al.
Published: (2025-05-01)

From the baker to the bedside: yeast models of Parkinson's disease
by: Regina Menezes, et al.
Published: (2015-07-01)

Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson’s disease
by: Maria Otero-Jimenez, et al.
Published: (2025-02-01)

Neuronal plasticity and its role in Alzheimer’s disease and Parkinson’s disease
by: Israt Jahan, et al.
Published: (2026-01-01)

Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
by: Filip Fredlund, et al.
Published: (2025-04-01)

Advancements in artificial synapses: The role of fluorite–structured ferroelectrics
by: P.R. Sekhar Reddy
Published: (2025-03-01)

Astrocytes and Tinnitus
by: Paola Perin, et al.
Published: (2024-11-01)

Heterosynaptic plasticity-induced modulation of synapses
by: Masoumeh Kourosh-Arami, et al.
Published: (2023-12-01)

Hydrophobic Carbon Dots Prevent α‐Synucleinopathy and Suppress Neuroinflammation to Treat Parkinson's Disease
by: Lihua Li, et al.
Published: (2025-03-01)

Novel approaches targeting α-Synuclein for Parkinson's Disease: Current progress and future directions for the disease-modifying therapies
by: David Baggett, et al.
Published: (2024-12-01)

The G209A mutation in the alpha-synuclein gene in Brazilian families with Parkinson's disease Mutação G209A no gene da alfa-sinucleína em famílias brasileiras com doença de Parkinson
by: Hélio A.G. Teive, et al.
Published: (2001-09-01)

Trans-sodium crocetinate ameliorates Parkinson-like disease caused by bisphenol A through inhibition of apoptosis and reduction of α-synuclein in rats
by: Majid Keshavarzi, et al.
Published: (2025-02-01)

A review of gut microbiota as a therapeutic approach for Parkinson’s disease
by: Debosree Ghosh, et al.
Published: (2024-12-01)

Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson’s disease
by: Alysia Ross, et al.
Published: (2025-07-01)

Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies
by: Caroline A. Barros, et al.
Published: (2025-04-01)

a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson’s Disease
by: Francesca Capotosti
Published: (2025-06-01)

NPT100-18A rescues mitochondrial oxidative stress and neuronal degeneration in human iPSC-based Parkinson’s model
by: Julian E. Alecu, et al.
Published: (2025-01-01)

Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
by: Fiona Weiss, et al.
Published: (2024-12-01)

The Imbalance of Homocysteine, Vitamin B12 and Folic Acid in Parkinson Plus Syndromes: A Review beyond Parkinson Disease
by: Vasiliki Poulidou, et al.
Published: (2024-09-01)

Potential biofluid markers for cognitive impairment in Parkinson’s disease
by: Jieyu Chen, et al.
Published: (2026-01-01)

Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson’s disease
by: Stefan Bräuer, et al.
Published: (2025-01-01)

The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
by: Yan Chen, et al.
Published: (2025-04-01)

A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies
by: Jamir Pitton Rissardo, et al.
Published: (2025-03-01)

Spatial transcriptome analysis of myenteric plexus and intestinal epithelium of colon in patients with Parkinson’s disease
by: Chaewon Shin, et al.
Published: (2025-07-01)

Exploring the Potential of Biomimetic Peptides in Targeting Fibrillar and Filamentous Alpha-Synuclein—An In Silico and Experimental Approach to Parkinson’s Disease
by: Sophia A. Frantzeskos, et al.
Published: (2024-11-01)